Page last updated: 2024-10-15

guanosine 5'-monophosphorothioate

Description

guanosine 5'-monophosphorothioate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135405922
CHEMBL ID1232922
SCHEMBL ID1092195
MeSH IDM0182553

Synonyms (13)

Synonym
CHEMBL1232922
gmps
guanosine, 5'-(dihydrogen phosphorothioate)
guanosine 5'-monophosphorothioate
76310-16-2
SCHEMBL1092195
DTXSID90227183
guanosine monophosphorothioate
guanosine-5'-monothiophosphate
5'-o-thiophosphonoguanosine
Q27460547
guanosine- 5'- o- monophosphorothioate ( 5'-gmps )
guanosine-5'-o-monophosphorothioate(5'-gmps)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1321604Drug level treated with 1-O-[(guanosin-5'-yl)thiophosphyl]-2-S-[(guanosin-5'-yl)dithiophosphyl]-ethane assessed as snake venom phosphodiesterase-mediated compound formation at 50 uM after 15 mins by RP-HPLC analysis2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Phosphorothioate analogs of P1,P3-di(nucleosid-5'-yl) triphosphates: Synthesis, assignment of the absolute configuration at P-atoms and P-stereodependent recognition by Fhit hydrolase.
AID1321605Retention time of compound by RP-HPLC analysis2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Phosphorothioate analogs of P1,P3-di(nucleosid-5'-yl) triphosphates: Synthesis, assignment of the absolute configuration at P-atoms and P-stereodependent recognition by Fhit hydrolase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (16.00)18.2507
2000's2 (8.00)29.6817
2010's6 (24.00)24.3611
2020's13 (52.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (3.85%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]